Skip to content
10-Q

Quarterly Report

ZIVO BIOSCIENCE, INC. ZIVO

0001654954-24-014463

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 8, 2024 3.55M sh
Current Liabilities Q3 2024 · Sep 30, 2024 $2.58M
Current Liabilities Q3 2024 · Dec 31, 2023 $2.76M
Total Liabilities Q3 2024 · Sep 30, 2024 $2.58M
Total Liabilities Q3 2024 · Dec 31, 2023 $2.76M
Current Assets Q3 2024 · Sep 30, 2024 $436.55K
Current Assets Q3 2024 · Dec 31, 2023 $425.38K
Total Assets Q3 2024 · Sep 30, 2024 $495.59K
Total Assets Q3 2024 · Dec 31, 2023 $555.72K
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$5.08M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$1.09M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$3.14M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$10.62K
Sga Expense Q3 2024 · Sep 30, 2023 $1.36M
Sga Expense Q3 2024 · Sep 30, 2023 $4.31M
Rd Expense Q3 2024 · Sep 30, 2023 $220.65K
Rd Expense Q3 2024 · Sep 30, 2023 $1.06M
Net Income Q3 2024 · Sep 30, 2023 −$1.82M
Net Income Q3 2024 · Sep 30, 2023 −$5.87M
Operating Income Q3 2024 · Sep 30, 2023 −$1.57M
Operating Income Q3 2024 · Sep 30, 2023 −$5.37M
Gross Profit Q3 2024 · Sep 30, 2023 $4.13K
Gross Profit Q3 2024 · Sep 30, 2023 $7.48K
Revenue Q3 2024 · Sep 30, 2023 $11.8K
Revenue Q3 2024 · Sep 30, 2023 $15.85K